Servier has commercialized more than 50 products and manufactures 27 billion units of drug product annually across a range of dosage forms, with full development and regulatory support.
We employ our state-of-the-art, high performance and maximum versatility production capacity for all main dosage forms and product groups. With 9 solid and liquid dose manufacturing sites, Servier CDMO has the capabilities to deliver your project from development through to the manufacture of large commercial batch sizes of tablets, capsules or powders. Servier has 60 years of experience with a proven track record of quality and regulatory approval to ensure reliability for your product. Capabilities include fluid-bed granulating, high-shear granulating, roller compacting, film coating and other advanced manufacturing technologies to ensure your product is made according to the highest quality standards.
9 solid and liquid dose manufacturing sites